Pormohammad Ali, Nasiri Mohammad Javad, Azimi Taher
Student Research Committee, Department of Microbiology, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Department of Microbiology, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Infect Drug Resist. 2019 May 8;12:1181-1197. doi: 10.2147/IDR.S201324. eCollection 2019.
Antimicrobial resistance is a serious public health problem worldwide. We aimed to investigate the prevalence of antibiotic resistance in strains simultaneously isolated from humans, animals, food, and the environment. Studies on PubMed, Embase, and the Cochrane Library published from January 1, 2000 to January 1, 2018 were searched. The quality of the included studies was assessed by the modified critical appraisal checklist recommended by the Joanna Briggs Institute. All analyses were conducted using Biostat's Comprehensive Meta-Analysis version 2.0. Depending on the heterogeneity test for each antibiotic, we used a random- or fixed-effect model for pooled prevalence of drug resistance. Studies were eligible if they had investigated and reported resistance in two or more isolation sources (human, animal, food, or environment). To decrease heterogeneity and bias, we excluded studies that had reported drug resistance isolated from one source only. We included publications that reported drug resistance with minimum inhibitory concentration or disk diffusion method (DDM) as antibiotic-susceptibility tests. Of the 39 included studies, 20 used the DDM and 19 minimum inhibitory concentration for their antibiotic-susceptibility testing. Colistin had the lowest prevalence, with 0.8% (95% CI 0.2%-3.8%) and amoxicillin the highest, with 70.5% (95% CI 57.5%-81%) in isolated human strains tested with the DDM. To assess historical changes in antimicrobial drug resistance, subgroup analysis from 2000 to 2018 showed a significant increase in ciprofloxacin resistance. Monitoring and evaluating antibiotic-sensitivity patterns and preparation of reliable antibiotic strategies may lead to better outcomes for inhibition and control of infections in different regions of the world.
抗菌药物耐药性是全球范围内一个严重的公共卫生问题。我们旨在调查同时从人类、动物、食物和环境中分离出的菌株的抗生素耐药性流行情况。检索了2000年1月1日至2018年1月1日在PubMed、Embase和Cochrane图书馆上发表的研究。纳入研究的质量由乔安娜·布里格斯研究所推荐的改良批判性评价清单进行评估。所有分析均使用Biostat的综合荟萃分析2.0版进行。根据每种抗生素的异质性检验,我们使用随机或固定效应模型来汇总耐药性的流行率。如果研究调查并报告了两种或更多分离源(人类、动物、食物或环境)中的耐药性,则该研究符合纳入标准。为了减少异质性和偏差,我们排除了仅报告从单一来源分离出的耐药性的研究。我们纳入了报告使用最低抑菌浓度或纸片扩散法(DDM)作为抗生素敏感性试验的耐药性的出版物。在纳入的39项研究中,20项使用DDM,19项使用最低抑菌浓度进行抗生素敏感性测试。在用DDM检测的分离出的人类菌株中,黏菌素的流行率最低,为0.8%(95%CI 0.2%-3.8%),阿莫西林最高,为70.5%(95%CI 57.5%-81%)。为了评估抗菌药物耐药性的历史变化,2000年至2018年的亚组分析显示环丙沙星耐药性显著增加。监测和评估抗生素敏感性模式以及制定可靠的抗生素策略可能会为全球不同地区的感染抑制和控制带来更好的结果。